It’s odd to see pharmaceutical marketing make a concerted effort to hype the need to represent the underrepresented in clinical trials—especially when history so clearly shows why the underrepresented should view such patronizing propaganda with suspicion. And it doesn’t help that White advertising agencies are behind the campaigns.
No comments:
Post a Comment